The Sandur Manganese & Iron Ores Limited announces resignation of Independent Director

Dr. Latha Pillai has resigned as an Independent Director from The Sandur Manganese & Iron Ores Limited, effective November 4, 2026. Her resignation is due to personal commitments. Consequently, she will also step down from her roles as Chairperson of the Nomination and Remuneration Committee and as a member of the Audit Committee, Stakeholders Relationship Committee, Risk Management Committee, and Corporate Sustainability Committee. The company has expressed gratitude for her contributions.

Key Personnel Change at The Sandur Manganese & Iron Ores Limited

The Sandur Manganese & Iron Ores Limited has officially announced the resignation of Dr. Latha Pillai from her position as an Independent Director. The resignation is effective from November 4, 2026, and is attributed to Dr. Pillai’s personal commitments. The company has formally accepted this decision, acknowledging its impact on the board and its committees.

Impact on Board Committees

In line with her resignation as an Independent Director, Dr. Pillai will also cease to hold her positions on several key committees. These include the Chairperson of the Nomination and Remuneration Committee, as well as membership on the Audit Committee, Stakeholders Relationship Committee, Risk Management Committee, and the Corporate Sustainability Committee. This necessitates a restructuring of these committees to fill the vacancies.

Company Acknowledgment

The Board of Directors and the management of The Sandur Manganese & Iron Ores Limited have formally placed on record their profound appreciation for the valuable contributions made by Dr. Latha Pillai during her tenure with the company. They extended their best wishes for her future endeavors.

Disclosure Requirements

The announcement has been made in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Detailed information, as required by SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, is provided in Annexure A. The copy of Dr. Pillai’s resignation letter, including the detailed reasons provided by her, is attached as Annexure B.

Source: BSE

Previous Article

Zee Entertainment Enterprises Limited monitoring report confirms preferential issue utilization

Next Article

Chordia Food Products reports Q2 2027 revenue of ₹81.78 lakhs